Trial Profile
A retrospective study to evaluate patient characteristics and dosage use of Secukinumab in the treatment of psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2016
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 01 Jun 2016 New trial record
- 25 May 2016 Results presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research